Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
36,825
Sort by:
Global Yersinia Diagnostics Market, 2019-2023: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment-US, Europe, Japan-Hospitals, Commercial and Public Health Labs, POC Locations
US$ 4,350.00
... of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Yersinia definition, epidemiology ... identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic ...
June 2019
197 pages
South Africa Molecular Diagnostics Market, 2019-2023: Supplier Sales and Shares, Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing-Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 4,250.00
... for instrument and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of ... on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular Technologies as corporate strategic assets, managed ...
June 2019
1120 pages
New Zealand Nucleic Acid Testing (NAT) Market, 2019-2023: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 4,250.00
... the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support ... analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal ...
June 2019
1120 pages